Literature DB >> 24737165

Aberrant expression of claudin-4 and -7 in hepatocytes in the cirrhotic human liver.

Mitsuhiro Tsujiwaki1, Masaki Murata, Akira Takasawa, Yutaro Hiratsuka, Rieko Fukuda, Kotaro Sugimoto, Yusuke Ono, Masanori Nojima, Satoshi Tanaka, Koichi Hirata, Takashi Kojima, Norimasa Sawada.   

Abstract

The liver comprises hepatocytes and non-parenchymal cells such as bile duct epithelial cells. Claudin-4 and -7 are not expressed in hepatocytes under physiological conditions. It was reported that claudin-7 increased in human pulmonary fibroses. We therefore investigated claudin-4 and -7 expressions in human cirrhotic livers, in which hepatocyte proliferation is severely delayed. We examined liver tissues from 50 patients with liver tumors. The expression of claudin-4 and -7 in hepatocytes significantly increased with the grade of fibrosis, not with inflammatory activity, in the liver tissues of chronic hepatitis. The number of claudin-4- and -7-positive cells observed was greater than that of alpha-fetoprotein-positive hepatic progenitor cells. In primary cultures of mouse hepatocytes, the expression of claudin-4 and -7 was not induced by treatment with proinflammatory cytokines. In immunohistochemical analysis of liver tissues of 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated mice and primary cultures of mouse hepatocytes, the expression of claudin-4 and -7 increased with proliferation of progenitor cells. However, the claudin-4- and -7-positive cells were not always progenitor cells. Thus, claudin-4 and -7 were observed in hepatocytes of severely damaged mouse and human livers. These findings suggest that claudin-4- and -7-positive hepatocytes may exist during the process of differentiation from progenitor cells into mature hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24737165     DOI: 10.1007/s00795-014-0074-z

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  36 in total

1.  Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice.

Authors:  Lei Ding; Zhe Lu; Oded Foreman; Rodney Tatum; Qun Lu; Randall Renegar; Jian Cao; Yan-Hua Chen
Journal:  Gastroenterology       Date:  2011-10-29       Impact factor: 22.682

Review 2.  Structure, function, and regulation of cellular tight junctions.

Authors:  E E Schneeberger; R D Lynch
Journal:  Am J Physiol       Date:  1992-06

3.  Thy1-positive cells have bipotential ability to differentiate into hepatocytes and biliary epithelial cells in galactosamine-induced rat liver regeneration.

Authors:  Junko Kon; Norihisa Ichinohe; Hidekazu Ooe; Qijie Chen; Kazunori Sasaki; Toshihiro Mitaka
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

4.  Expression and function of claudins in hepatocytes.

Authors:  Takashi Kojima; Norimasa Sawada
Journal:  Methods Mol Biol       Date:  2011

Review 5.  Tight junctions and the molecular basis for regulation of paracellular permeability.

Authors:  J M Anderson; C M Van Itallie
Journal:  Am J Physiol       Date:  1995-10

6.  The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7.

Authors:  Markus Ladwein; Ulrich-Frank Pape; Dirk-Steffen Schmidt; Martina Schnölzer; Sabine Fiedler; Lutz Langbein; Werner W Franke; Gerhard Moldenhauer; Margot Zöller
Journal:  Exp Cell Res       Date:  2005-10-01       Impact factor: 3.905

7.  Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers.

Authors:  Bryon E Petersen; Brian Grossbard; Heather Hatch; Liya Pi; Jie Deng; Edward W Scott
Journal:  Hepatology       Date:  2003-03       Impact factor: 17.425

8.  Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions.

Authors:  Chuan-Jin Wu; Poonam Mannan; Michael Lu; Mark C Udey
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

9.  Streptozotocin-induced diabetes can be reversed by hepatic oval cell activation through hepatic transdifferentiation and pancreatic islet regeneration.

Authors:  Seungbum Kim; Jun-Seop Shin; Hyun-Jung Kim; Robert C Fisher; Mi-Ji Lee; Chan-Wha Kim
Journal:  Lab Invest       Date:  2007-05-07       Impact factor: 5.662

10.  Expression of hepatocyte epidermal growth factor receptor, FAS and glypican 3 in EpCAM-positive regenerative clusters of hepatocytes, cholangiocytes, and progenitor cells in human liver failure.

Authors:  Alex Hattoum; Erin Rubin; Anne Orr; George K Michalopoulos
Journal:  Hum Pathol       Date:  2012-10-29       Impact factor: 3.466

View more
  8 in total

1.  Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Authors:  Gen Yamada; Masaki Murata; Akira Takasawa; Masanori Nojima; Yuki Mori; Norimasa Sawada; Hiroki Takahashi
Journal:  Med Mol Morphol       Date:  2016-02-12       Impact factor: 2.309

2.  Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat.

Authors:  Patric Schyman; Richard L Printz; Venkat R Pannala; Mohamed Diwan M AbdulHameed; Shanea K Estes; Chiyo Shiota; Kelli Lynn Boyd; Masakazu Shiota; Anders Wallqvist
Journal:  Toxicol Appl Pharmacol       Date:  2021-09-04       Impact factor: 4.219

3.  Human Claudin-7 cis-Interactions Are Not Crucial for Membrane-Membrane (Trans-) Interactions.

Authors:  Lena Ahlswede; Carmen Siebenaller; Benedikt Junglas; Nadja Hellmann; Dirk Schneider
Journal:  Front Mol Biosci       Date:  2022-06-27

Review 4.  Claudins in cancer: bench to bedside.

Authors:  Makoto Osanai; Akira Takasawa; Masaki Murata; Norimasa Sawada
Journal:  Pflugers Arch       Date:  2016-09-13       Impact factor: 3.657

5.  Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.

Authors:  Yusuke Ono; Yutaro Hiratsuka; Masaki Murata; Akira Takasawa; Rieko Fukuda; Masanori Nojima; Satoshi Tanaka; Makoto Osanai; Koichi Hirata; Norimasa Sawada
Journal:  Virchows Arch       Date:  2016-07-21       Impact factor: 4.064

6.  Severe Intestinal Inflammation in the Small Intestine of Mice Induced by Controllable Deletion of Claudin-7.

Authors:  Wen-Jing Li; Chang Xu; Kun Wang; Teng-Yan Li; Xiao-Nan Wang; Hui Yang; Tiaosi Xing; Wen-Xia Li; Yan-Hua Chen; Hong Gao; Lei Ding
Journal:  Dig Dis Sci       Date:  2018-02-27       Impact factor: 3.199

7.  Expression of hnRNPK & Claudin-4 in HCV-Induced Early HCC and Adjacent Liver Tissue.

Authors:  Olfat Hammam; Mona Magdy; Amgad Anas; Ali Abdel Rahim; Mohamed Heedaya; Ahmed Helmy
Journal:  Open Access Maced J Med Sci       Date:  2017-07-31

Review 8.  Emerging clinical significance of claudin-7 in colorectal cancer: a review.

Authors:  Kun Wang; Chang Xu; Wenjing Li; Lei Ding
Journal:  Cancer Manag Res       Date:  2018-09-20       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.